Efficacy and safety of low- and ultralow-dose rituximab in neuromyelitis optica spectrum disorder. Zhang C, Liu R, Gao B, Li T, et al. J Neuroimmunol 2024;387:578285.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang C, Liu R, Gao B, Li T, et al. Efficacy and safety of low- and ultralow-dose rituximab in neuromyelitis optica spectrum disorder. J Neuroimmunol 2024;387:578285.
PMID: 38219400